Cointime

ProThera Biologics

company

About

ProThera Biologics focuses on unmet medical needs by developing integrated theranostic and therapeutic biomolecules.

  • 11 - 50

Highlights

Total Funding Amount
$750K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$750K
Industries
Biotechnology,Clinical Trials,Health Care,Therapeutics
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

ProThera Biologics was established in the state of Rhode Island in 2001 by Yow-Pin Lim, MD/PhD, Assistant Professor of Medicine, Brown Medical School and Douglas C. Hixson, PhD, Professor of Medicine and Pathology/ Laboratory Medicine, Brown Medical School. Both co-founders are actively engaged in the biomedical research in the Carcinogenesis Laboratory at Rhode Island Hospital, where Dr. Hixson is the longstanding Research Director and Dr. Lim is a Research Oncologist.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$750K
ProThera Biologics has raised a total of $750K in funding over 2 rounds. Their latest funding was raised on Sep 5, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 5, 2012 Series Unknown $750K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
ProThera Biologics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Series Unknown
Cointime
เนื้อหา
บริษัท